Rouven Bergmann

다쏘시스템 생명과학 최고 운영 책임자

Rouven Bergmann is chief operating officer (COO) of Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), which powers smarter treatments and healthier people.

Bergmann is responsible for the global operations of Medidata. He also oversees the company’s strategic finance, capital management, tax, controllership, procurement operations, expense management and treasury.

Bergmann who joined during 2015 as CFO of Medidata, a fast-growing public SaaS company led the financial strategy of growing the business from $300M to more than $700M at the time of the acquisition by Dassault Systèmes in 2019. With the acquisition, he transitioned his responsibilities as a public company CFO to COO responsible for managing the execution plan of the acquisition and day-to-day global operations of Medidata.

Prior to joining Medidata, Bergmann was CFO of SAP North America, a multi-billion dollar software business where he was responsible for overseeing all financial activities for SAP’s largest business unit. His key accomplishments include driving SAP’s transition from a traditional licensing model to SaaS and leading transformational acquisition integrations. Since joining SAP in 2005, Rouven served as chief operating officer for SAP’s global R&D organization, as well as held key leadership roles in Germany; Bangalore, India; and the U.S. in Palo Alto, Calif. and NYC.

Bergmann holds masters degrees in mechanical engineering and business administration from Technical University of Kaiserslautern in Germany, and a PhD in economics and finance from the University of Munich in Germany.

Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,600+ customers and partners access the world's most-used platform for clinical development, commercial, and real-world data.